Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Can We Personalize Treatment for Kidney Diseases
Clinical Journal of the American Society of Nephrology, 10/08/09
Rovin BH et al. – Data on adjusting therapy on the basis of pharmacogenetics/genomics and pharmacodynamics are summarized to demonstrate where the field is, and biomarker studies that reflect the future of personalized medicine are discussed. The goal of this review is to demonstrate that we can personalize therapy for kidney diseases but that considerable investment in new research will be required for personalized medicine to be routinely used in nephrology clinics.
Related Articles
Understanding Diabetes Mellitus And Kidney Disease
Nephrology Nursing Journal, 10/02/09
Relevance Score: 71%
Diabetic kidney disease in the older adult: an update
Aging Health, 10/07/09
Relevance Score: 70%
The Intersection of Geriatrics and Chronic Kidney Disease: Frailty and Disability Among Older Adults With Kidney Disease
Advances In Chronic Kidney Disease, 10/07/09
Relevance Score: 70%
Charcoal Treats Heart Disease
Ivanhoe, 11/05/09
Relevance Score: 69%
Can charcoal fight heart disease in kidney patients?
EurekAlert, 11/02/09
Relevance Score: 69%
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Journal of Clinical Oncology, 12/09/09
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A double-blind, randomised trial
The Lancet Oncology - Online First, 12/09/09
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/09/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection
Phlebology, 12/09/09
Magnetic Resonance Imaging in Lewy Body Dementias
Dementia and Geriatric Cognitive Disorders, 12/09/09
Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men
BJU International, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


